Defective mitochondrial morphology and bioenergetic function in mice lacking the transcription factor Yin Yang 1 in skeletal muscle
- PMID: 22711985
- PMCID: PMC3434543
- DOI: 10.1128/MCB.00337-12
Defective mitochondrial morphology and bioenergetic function in mice lacking the transcription factor Yin Yang 1 in skeletal muscle
Abstract
The formation, distribution, and maintenance of functional mitochondria are achieved through dynamic processes that depend strictly on the transcription of nuclear genes encoding mitochondrial proteins. A large number of these mitochondrial genes contain binding sites for the transcription factor Yin Yang 1 (YY1) in their proximal promoters, but the physiological relevance is unknown. We report here that skeletal-muscle-specific YY1 knockout (YY1mKO) mice have severely defective mitochondrial morphology and oxidative function associated with exercise intolerance, signs of mitochondrial myopathy, and short stature. Gene set enrichment analysis (GSEA) revealed that the top pathways downregulated in YY1mKO mice were assigned to key metabolic and regulatory mitochondrial genes. This analysis was consistent with a profound decrease in the level of mitochondrial proteins and oxidative phosphorylation (OXPHOS) bioenergetic function in these mice. In contrast to the finding for wild-type mice, inactivation of the mammalian target of rapamycin (mTOR) did not suppress mitochondrial genes in YY1mKO mice. Mechanistically, mTOR-dependent phosphorylation of YY1 resulted in a strong interaction between YY1 and the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator 1α (PGC1α), a major regulator of mitochondrial function. These results underscore the important role of YY1 in the maintenance of mitochondrial function and explain how its inactivation might contribute to exercise intolerance and mitochondrial myopathies.
Figures










Similar articles
-
Skeletal muscle increases FGF21 expression in mitochondrial disorders to compensate for energy metabolic insufficiency by activating the mTOR-YY1-PGC1α pathway.Free Radic Biol Med. 2015 Jul;84:161-170. doi: 10.1016/j.freeradbiomed.2015.03.020. Epub 2015 Apr 3. Free Radic Biol Med. 2015. PMID: 25843656
-
mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex.Nature. 2007 Nov 29;450(7170):736-40. doi: 10.1038/nature06322. Nature. 2007. PMID: 18046414
-
Nuclear receptor Nur77 and Yin-Yang 1 synergistically increase mitochondrial abundance and activity in macrophages.FEBS Lett. 2024 Jul;598(14):1715-1729. doi: 10.1002/1873-3468.14942. Epub 2024 Jun 2. FEBS Lett. 2024. PMID: 38825601
-
The Yin and Yang of YY1 in tumor growth and suppression.Int J Cancer. 2018 Aug 1;143(3):460-465. doi: 10.1002/ijc.31255. Epub 2018 Jan 31. Int J Cancer. 2018. PMID: 29322514 Review.
-
Oncogenic potential of yin yang 1 mediated through control of imprinted genes.Crit Rev Oncog. 2011;16(3-4):199-209. doi: 10.1615/critrevoncog.v16.i3-4.40. Crit Rev Oncog. 2011. PMID: 22248054 Free PMC article. Review.
Cited by
-
Regulation of Skeletal Muscle Atrophy in Cachexia by MicroRNAs and Long Non-coding RNAs.Front Cell Dev Biol. 2020 Sep 15;8:577010. doi: 10.3389/fcell.2020.577010. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33043011 Free PMC article. Review.
-
The neuroprotective effects of glucagon-like peptide 1 in Alzheimer's and Parkinson's disease: An in-depth review.Front Neurosci. 2022 Sep 1;16:970925. doi: 10.3389/fnins.2022.970925. eCollection 2022. Front Neurosci. 2022. PMID: 36117625 Free PMC article. Review.
-
Lack of muscle mTOR kinase activity causes early onset myopathy and compromises whole-body homeostasis.J Cachexia Sarcopenia Muscle. 2019 Feb;10(1):35-53. doi: 10.1002/jcsm.12336. Epub 2018 Nov 21. J Cachexia Sarcopenia Muscle. 2019. PMID: 30461220 Free PMC article.
-
Rapamycin doses sufficient to extend lifespan do not compromise muscle mitochondrial content or endurance.Aging (Albany NY). 2013 Jul;5(7):539-50. doi: 10.18632/aging.100576. Aging (Albany NY). 2013. PMID: 23929887 Free PMC article.
-
Recent advances in mitochondrial turnover during chronic muscle disuse.Integr Med Res. 2014 Dec;3(4):161-171. doi: 10.1016/j.imr.2014.09.001. Epub 2014 Sep 10. Integr Med Res. 2014. PMID: 28664093 Free PMC article. Review.
References
-
- Austen M, Luscher B, Luscher-Firzlaff JM. 1997. Characterization of the transcriptional regulator YY1. The bipartite transactivation domain is independent of interaction with the TATA box-binding protein, transcription factor IIB, TAFII55, or cAMP-responsive element-binding protein (CPB)-binding protein. J. Biol. Chem. 272:1709–1717 - PubMed
-
- Bentzinger CF, et al. 2008. Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metab. 8:411–424 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous